Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
62.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (4.065%)
Market Cap: £5.76m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Company Update

10 Apr 2026 12:34

RNS Number : 0371A
CPPGroup PLC
10 April 2026
 

CPPGroup Plc

("CPP"; "the Group"; or "the Company")

 

COMPANY UPDATE

 

The Board of CPP Group provides the following update on the strategic options currently being actively progressed, subsequent to the Company's announcement on 16th March.

 

Strategic review and potential sale of Blink

The Board is exploring strategic options for Blink Parametric Holdings Limited ("Blink"), the Group's digitally focused parametric InsurTech business, which has received significant investment in recent years and continues to perform strongly and in line with Board expectations.

 

Blink is a technology-led platform providing real-time, automated claims assessment and payment solutions, primarily within the travel disruption insurance and cyber protection markets. It has established a growing network of global partnerships with insurers, financial institutions and travel providers, with an expanding presence across multiple geographies.

 

For the year ended 31 December 2025, Blink is expected to report annualised recurring revenue ("ARR") of circa £3 million (2024: £1.6 million), representing strong year-on-year growth. This momentum has continued with a strong Q1 2026, and we expect, by year end, to report another year of strong revenue growth.

 

The Board is encouraged by the level of external interest in Blink and has received proposals and expressions of interest, including from strategic industry participants, in relation to a potential acquisition or combination involving the business. The proposals reflect valuation levels which are significantly in excess of the Group's current market capitalisation, reinforcing confidence in Blink's underlying value and future growth potential.

 

The Board is therefore pursuing a potential sale of Blink. No terms have been agreed at this stage, and there can be no certainty that any transaction will be completed or as to the value that may ultimately be realised.

 

Liquidity and Financing

Whilst the Group does not expect to receive any deferred consideration in relation to the disposal of CPP India, the validity of the reasons presented by the purchaser of CPP India continue to be questioned. Based on the Group's current resources of approximately £4 million, together with the Board's assessment of the regulatory capital requirements of its legacy regulated businesses, and in the absence of new capital, the Company currently expects to have sufficient resources to fund its working capital requirements through to the end of the third quarter of 2026.

 

In light of this, the Board is also progressing discussions with a range of parties, including existing shareholders and potential new investors, regarding funding options to support the Group. These discussions are focused on enhancing financial flexibility in order to:

 

1. fund the Group's ongoing operating requirements;

2. support the continued development and growth of Blink;

3. provide capital for the regulated businesses in run-off; and

4. extend the Group's available cash runway.

 

A range of funding structures is under consideration, and a further announcement will be made in due course.

 

The Board remains focused on delivering an outcome that maximises shareholder value while ensuring the Group maintains an appropriate and sustainable funding position.

 

 

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of CPP Group is Sarah Atherton, General Counsel and Company Secretary.

 

 

 

 

ENQUIRIES

 

CPPGroup plc

David Morrison, Chairman via H2 Radnor Email: info@h2radnor.com

Simon Pyper, Chief Financial Officer Tel: +44 (0)203 897 1830

 

Panmure Liberum

(Nominated Adviser and Sole Broker) Tel: +44 (0)20 310 2000

Stephen Jones

Atholl Tweedie

Will King

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBBGDSDXBDGLG
Date   Source Headline
5th Mar 20217:00 amRNSDirectorate Change - Amendment
11th Feb 20217:00 amRNSBlock listing Interim Review
5th Feb 20218:34 amRNSDirectorate Change
18th Jan 20217:00 amRNSTrading Update
21st Dec 20205:32 pmRNSDirector/PDMR Shareholding
17th Dec 202012:26 pmRNSBlock listing Interim Review
30th Nov 20203:47 pmRNSDirectorate Change
13th Nov 20207:00 amRNSDirectorate Change
2nd Nov 202011:38 amRNSTotal Voting Rights
26th Oct 20201:30 pmRNSBlock listing Interim Review
5th Oct 202011:09 amRNSTotal Voting Rights
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:02 pmRNSNon Regulatory - Blink - Lloyds Lab
18th Aug 202010:19 amRNSBusiness Update
13th Aug 20207:17 amRNSBlock listing Interim Review
1st Jul 20208:29 amRNSTotal Voting Rights
30th Jun 20208:08 amRNSBlock listing Interim Review
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
9th Jun 20209:37 amRNSDirectorate Change
28th May 202012:32 pmRNSResult of AGM
22nd May 202012:28 pmRNSTotal Voting Rights
20th May 202012:08 pmRNSSecond Price Monitoring Extn
20th May 202012:02 pmRNSPrice Monitoring Extension
19th May 202011:10 amRNSBusiness Update
1st May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:42 pmRNSNotice of AGM
21st Apr 20202:48 pmRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSFinal Results
14th Apr 20203:36 pmRNSAdditional Listing
23rd Mar 20201:17 pmRNSTrading Statement
23rd Mar 20207:00 amRNSStatement re delayed preliminary results
12th Mar 202010:13 amRNSAdditional Listing
24th Feb 202011:40 amRNSBusiness Update
11th Feb 20204:24 pmRNSBlock listing Interim Review
10th Feb 202012:43 pmRNSCPP Group India Risk award
6th Feb 20204:41 pmRNSSecond Price Monitoring Extn
6th Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20201:22 pmRNSCPP advances technology offering in Turkey
20th Dec 20199:50 amRNSDirector/PDMR Shareholding
16th Dec 201912:08 pmRNSBlock listing Interim Review
12th Dec 201911:16 amRNSDirector/PDMR Shareholding
28th Nov 201911:03 amRNSBusiness Update
12th Nov 20192:40 pmRNSBusiness Update
4th Nov 20194:11 pmRNSTotal Voting Rights
21st Oct 20192:16 pmRNSBusiness update
18th Oct 201912:07 pmRNSSecond Price Monitoring Extn
18th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20199:04 amRNSTotal Voting Rights
11th Sep 20198:43 amRNSBusiness Update
9th Sep 20193:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.